Renovaro Biosciences
RENB
#7734
Rank
NZ$0.46 B
Marketcap
$2.90
Share price
6.15%
Change (1 day)
-43.86%
Change (1 year)

EPS for Renovaro Biosciences (RENB)

EPS in 2023 (TTM): -$3.26

According to Renovaro Biosciences's latest financial reports the company's current EPS (TTM) is -$3.57. In 2022 the company made an earnings per share (EPS) of -$3.64 a decrease over its 2021 EPS that were of -$1.40.

EPS history for Renovaro Biosciences from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.26-10.44%
2022-$3.64160.76%
2021-$1.40243.48%
2020-$0.4143.75%
2019-$0.28-74.87%
2018-$1.13339.47%
2017-$0.26-48.26%
2016-$0.49-22.22%
2015-$0.647.39%
2014-$0.594351.27%
2013-$0.0133116.6%
2012-$0.01141